CN102575224A - 用于预防和治疗过敏的益生菌衍生的无活力材料 - Google Patents

用于预防和治疗过敏的益生菌衍生的无活力材料 Download PDF

Info

Publication number
CN102575224A
CN102575224A CN201080040659XA CN201080040659A CN102575224A CN 102575224 A CN102575224 A CN 102575224A CN 201080040659X A CN201080040659X A CN 201080040659XA CN 201080040659 A CN201080040659 A CN 201080040659A CN 102575224 A CN102575224 A CN 102575224A
Authority
CN
China
Prior art keywords
composition
lgg
supernatant
allergic
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201080040659XA
Other languages
English (en)
Chinese (zh)
Inventor
E·A·F·范托尔
W·M·拉塞尔
U·赫尔斯
H·伦斯
H·加恩
M·布拉克斯马
M·J·范德维尔夫
K·M·奥弗坎普
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MJN US Holdings LLC
Original Assignee
Mead Johnson Nutrition Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mead Johnson Nutrition Co filed Critical Mead Johnson Nutrition Co
Publication of CN102575224A publication Critical patent/CN102575224A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/304—Foods, ingredients or supplements having a functional effect on health having a modulation effect on allergy and risk of allergy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pediatric Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN201080040659XA 2009-09-11 2010-09-10 用于预防和治疗过敏的益生菌衍生的无活力材料 Pending CN102575224A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09170124A EP2295535A1 (en) 2009-09-11 2009-09-11 Probiotic material
EP09170124.3 2009-09-11
PCT/NL2010/050576 WO2011031149A1 (en) 2009-09-11 2010-09-10 Probiotic derived non-viable material for allergy prevention and treatment

Publications (1)

Publication Number Publication Date
CN102575224A true CN102575224A (zh) 2012-07-11

Family

ID=41561153

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201080040659XA Pending CN102575224A (zh) 2009-09-11 2010-09-10 用于预防和治疗过敏的益生菌衍生的无活力材料

Country Status (20)

Country Link
US (1) US20110217402A1 (cg-RX-API-DMAC7.html)
EP (2) EP2295535A1 (cg-RX-API-DMAC7.html)
JP (1) JP2013504321A (cg-RX-API-DMAC7.html)
KR (1) KR20120061836A (cg-RX-API-DMAC7.html)
CN (1) CN102575224A (cg-RX-API-DMAC7.html)
AU (1) AU2010293145B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012005533A2 (cg-RX-API-DMAC7.html)
CA (1) CA2772593C (cg-RX-API-DMAC7.html)
EC (1) ECSP12011786A (cg-RX-API-DMAC7.html)
ES (1) ES2614929T3 (cg-RX-API-DMAC7.html)
IN (1) IN2012DN00951A (cg-RX-API-DMAC7.html)
MX (1) MX345077B (cg-RX-API-DMAC7.html)
MY (1) MY160646A (cg-RX-API-DMAC7.html)
NZ (1) NZ597818A (cg-RX-API-DMAC7.html)
PE (1) PE20121557A1 (cg-RX-API-DMAC7.html)
PL (1) PL2475764T3 (cg-RX-API-DMAC7.html)
RU (1) RU2012114190A (cg-RX-API-DMAC7.html)
SG (1) SG178230A1 (cg-RX-API-DMAC7.html)
TW (1) TWI595090B (cg-RX-API-DMAC7.html)
WO (1) WO2011031149A1 (cg-RX-API-DMAC7.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106879253A (zh) * 2014-05-20 2017-06-20 拜奥加亚公司 新生儿微生物组补充
CN111315413A (zh) * 2017-11-07 2020-06-19 秀比特生物技术公司 通过IgE类特异性免疫反应的抑制效果阻止婴儿期变态反应素质获得的方法
CN119040223A (zh) * 2024-11-01 2024-11-29 微康益生菌(苏州)股份有限公司 一种具有抗炎抗敏功效的鼠李糖乳酪杆菌rh22及其应用

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130095189A1 (en) * 2011-10-14 2013-04-18 Zeina Jouni Composition and method of phytonutrients for metabolic programming effects
US20130251829A1 (en) * 2012-03-23 2013-09-26 Mead Johnson Nutrition Company Probiotic derived non-viable material for infection prevention and treatment
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9345727B2 (en) * 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US8889633B2 (en) * 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US20150305384A1 (en) * 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
US9730969B2 (en) 2015-11-06 2017-08-15 Mead Johnson Nutrition Company Nutritional compositions for promoting gut barrier function and ameliorating visceral pain
US10034937B2 (en) 2015-12-04 2018-07-31 Mead Johnson Nutrition Company Synergistic nutritional compositions and uses thereof
JP7057059B2 (ja) 2016-08-22 2022-04-19 株式会社明治 ラクトバチルス・プランタラムの培養物の製造方法
US20180064739A1 (en) 2016-09-06 2018-03-08 Mead Johnson Nutrition Company Nutritional composition with human milk oligosaccharides and uses thereof
US20180103675A1 (en) 2016-10-14 2018-04-19 Mead Johnson Nutrition Company Personalized pediatric nutrition products comprising human milk oligosaccharides
US10980269B2 (en) 2016-12-12 2021-04-20 Mead Johnson Nutrition Company Protein hydrolysates and methods of making same
US20180161292A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180160714A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180168215A1 (en) 2016-12-21 2018-06-21 Mead Johnson Nutrition Company Nutritional compositions containing inositol and uses thereof
US20180332881A1 (en) 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Preterm infant formula containing butyrate and uses thereof
US20180333426A1 (en) 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Nutritional composition with human milk oligosaccharides and uses thereof
US20190208807A1 (en) 2018-01-05 2019-07-11 Mead Johnson Nutrition Company Nutritional compositions containing milk-derived peptides and uses thereof
EP3524051A1 (en) * 2018-02-12 2019-08-14 DuPont Nutrition Biosciences ApS Matricial microencapsulation compositions

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1187772A (zh) * 1995-06-14 1998-07-15 瓦里欧公司 预防或治疗过敏的方法
CN1838888A (zh) * 2003-06-23 2006-09-27 雀巢技术公司 婴儿或第二阶段配方奶
CN1997748A (zh) * 2004-04-20 2007-07-11 芝加哥大学 来自乳杆菌gg的益生化合物及其用途
CN101160135A (zh) * 2005-04-15 2008-04-09 布里斯托尔-迈尔斯斯奎布公司 Lgg在制造用于预防或治疗呼吸变态反应的药物中的用途

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
ZA92452B (en) 1991-01-24 1992-10-28 Martek Corp Microbial oil mixtures and uses thereof
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
US6506389B2 (en) 1995-10-20 2003-01-14 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek (Tno) Adherence factors of non pathogenic microorganisms and applications thereof for screening microorganisms for specific probiotic properties; novel pharmaceutical compositions and food additives comprising such microorganisms and adherence factors
CA2206674A1 (en) * 1996-05-30 1997-11-30 Gregor Reid Lactobacillus therapies
EP0904784A1 (en) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
WO2000071138A2 (en) * 1999-05-25 2000-11-30 Gregor Reid Oral administration of lactobacillus for the maintenance of health in women
NZ536894A (en) 2000-08-08 2006-04-28 Vialactia Bioscience Nz Ltd Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
EP1458247B1 (en) * 2001-12-20 2014-01-22 Biolactis Inc. Malleable protein matrix and uses thereof
EP1572145A1 (en) * 2002-12-13 2005-09-14 L'oreal Use of an extract of decaffeinated coffee beans in the preparation of a composition intended to stimulate the sebaceous function of the skin by oral administration
US20040208863A1 (en) 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
US20100233312A9 (en) * 2005-04-11 2010-09-16 The Procter & Gamble Company Compositions comprising probiotic and sweetener components
US7303745B2 (en) * 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
US9133249B2 (en) * 2006-10-24 2015-09-15 Vanderbilt University Compositions and methods for the treatment of disorders involving epithelial cell apoptosis
JP2010523695A (ja) * 2007-04-11 2010-07-15 アルコン リサーチ， リミテッド アレルギー性鼻炎およびアレルギー性結膜炎を処置するためのＴＮＦαのインヒビターおよび抗ヒスタミン薬の使用
WO2009137159A2 (en) * 2008-04-17 2009-11-12 Trustees Of Dartmouth College Bioactive molecules produced by probiotic bacteria and methods for isolating and using the same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1187772A (zh) * 1995-06-14 1998-07-15 瓦里欧公司 预防或治疗过敏的方法
CN1838888A (zh) * 2003-06-23 2006-09-27 雀巢技术公司 婴儿或第二阶段配方奶
CN1997748A (zh) * 2004-04-20 2007-07-11 芝加哥大学 来自乳杆菌gg的益生化合物及其用途
CN101160135A (zh) * 2005-04-15 2008-04-09 布里斯托尔-迈尔斯斯奎布公司 Lgg在制造用于预防或治疗呼吸变态反应的药物中的用途

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHANG HWAN CHOI 等: "Effect of Lactobacillus GG and conditioned media on IL-1b-induced IL-8 production in Caco-2 cells", 《SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY》 *
JEREMY ANDREW PEñA 等: "Lactobacillus rhamnosus GG decreases TNF-α production in lipopolysaccharide-activated murine macrophages by a contact-independent mechanism", 《CELLULAR MICROBIOLOGY》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106879253A (zh) * 2014-05-20 2017-06-20 拜奥加亚公司 新生儿微生物组补充
CN111315413A (zh) * 2017-11-07 2020-06-19 秀比特生物技术公司 通过IgE类特异性免疫反应的抑制效果阻止婴儿期变态反应素质获得的方法
CN119040223A (zh) * 2024-11-01 2024-11-29 微康益生菌(苏州)股份有限公司 一种具有抗炎抗敏功效的鼠李糖乳酪杆菌rh22及其应用
CN119040223B (zh) * 2024-11-01 2025-02-28 微康益生菌(苏州)股份有限公司 一种具有抗炎抗敏功效的鼠李糖乳酪杆菌rh22及其应用

Also Published As

Publication number Publication date
SG178230A1 (en) 2012-03-29
EP2475764B1 (en) 2016-12-14
EP2475764A1 (en) 2012-07-18
ES2614929T3 (es) 2017-06-02
TWI595090B (zh) 2017-08-11
JP2013504321A (ja) 2013-02-07
IN2012DN00951A (cg-RX-API-DMAC7.html) 2015-04-10
US20110217402A1 (en) 2011-09-08
EP2295535A1 (en) 2011-03-16
TW201124529A (en) 2011-07-16
RU2012114190A (ru) 2013-10-20
KR20120061836A (ko) 2012-06-13
ECSP12011786A (es) 2012-07-31
PE20121557A1 (es) 2012-11-21
BR112012005533A2 (pt) 2016-04-26
CA2772593C (en) 2018-11-27
CA2772593A1 (en) 2011-03-17
MX2012002716A (es) 2012-04-19
MX345077B (es) 2017-01-16
PL2475764T3 (pl) 2017-06-30
AU2010293145A1 (en) 2012-03-08
AU2010293145B2 (en) 2016-04-14
MY160646A (en) 2017-03-15
WO2011031149A1 (en) 2011-03-17
NZ597818A (en) 2014-01-31

Similar Documents

Publication Publication Date Title
AU2010293145B2 (en) Probiotic derived non-viable material for allergy prevention and treatment
EP2378890B1 (en) Prevention and treatment of rotavirus diarrhoea
EP2114423B2 (en) Inactivated lactobacillus rhammosus gg for treating systemic inflammation in infants
AU2013235365B2 (en) Probiotic derived non-viable material for infection prevention and treatment
JP7296454B2 (ja) 炎症関連胃腸障害の処置のためのプロバイオティクスの組み合わせ
US20160303226A1 (en) Heat-treated formulation of bifidobacterium lactis ncc 2818 reduces allergic manifestations
JP2022514553A (ja) アレルギー性疾患の治療のためのプロバイオティクスの組み合わせ
JP2013538827A (ja) 腎機能を増強させるための組成物および方法
Vester et al. Prebiotics and probiotics in companion animal nutrition.
US20240261346A1 (en) Nutritional composition for improving infant microbiota
HK1172928A (en) Probiotic derived non-viable material for allergy prevention and treatment
HK1136969B (en) Product containing inactivated probiotic for infants

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1172928

Country of ref document: HK

ASS Succession or assignment of patent right

Owner name: MJN USA HOLDING CO., LTD.

Free format text: FORMER OWNER: MEAD JOHNSON NUTRITION COMPANY

Effective date: 20130701

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20130701

Address after: Illinois, USA

Applicant after: MJN U.S. HOLDINGS LLC

Address before: Indiana, USA

Applicant before: MEAD JOHNSON NUTRITION Co.

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1172928

Country of ref document: HK

AD01 Patent right deemed abandoned

Effective date of abandoning: 20201013

AD01 Patent right deemed abandoned